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A technique of orthotopic liver transplantation using a segmental graft from living donors was
developed in the dog. Male mongrel dogs weighing 25-30 kg were used as donors and 10-15 kg as
recipients. The donor operation consists of harvesting the left lobe of the liver (left medial and left
lateral segments) with the left branches of the portal vein, hepatic artery and bile duct, and the left
hepatic vein. The grafts are perfused in situ through the left portal bran6h to prevent warm ischemia.
The recipient operation consists of two phases: total hepatectomy with preservation of the inferior
vena cava using total vascular exclusion of the liver and veno-venous bypass, implantation of the graft
in the orthotopic position with anastomosis of the left hepatic vein to the inferior vena cava and portal,
arterial and biliary reconstruction. Preliminary experiments consisted of four autologous left lobe
transplants and nine non survival allogenic left lobe transplants. Ten survival experiments were
conducted. There were no intraoperative deaths in the donors and none required transfusions. One
donor died of sepsis, but all the other donor dogs survived without complication. Among the 10 grafts
harvested, one was not used because of insufficient bile duct and artery. Two recipients died
intraoperatively of air embolus and cardiac arrest at the time of reperfusion. Three dogs survived, two
for 24 hours and one for 48 hours. They were awake and alert a few hours after surgery, but eventually
died of pulmonary edema in 2 cases and of an unknown reason in the other. Four dogs died 2-12 hours
postoperatively as a result of hemorrhage for the graft’s transected surface. An outflow block after
reperfusion was deemed to be the cause of hemorrhage in these cases. On histologic examination of the
grafts, there were no signs of ischemic necrosis or preservation damage.
This study demonstrates the technical feasibility of living hepatic allograft donation. It shows that it is
possible, in the dog, to safely harvest non ischemic segmental grafts with adequate pedicles without
altering the vascularization and the biliary drainage of the remaining liver. We propose that this
technique is applicable to human anatomy.
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INTRODUCTION
Orthotopic liver transplantation (OLT) can be life saving for infants and children
with severe liver disease. However, many of these patients progress to end stage at
a young age when donor organs are relatively unavailable. For example, of 35
children with biliary atresia who died during the process of OLT in one series, 25
died while waiting on the list for lack of a donor . Also, rapidly progressive
diseases such as fulminant hepatitis do not allow adequate time to obtain a donor,
which increases overall mortality. These considerations have prompted the deve-
lopment of alternative approaches including reduced-size grafts
2-5 and recently
dividing one organ to serve two recipients 6. Although the use of living donors for
liver transplantation has been postulated in the literature since the 1960s
7,8 this
approach has received little attention in the experimental laboratory and, to our
knowledge, has not been attempted clinically. It would represent a further step to
reduce the shortage of grafts for young children.
There are, however, several important constraints to using living related liver
donors. The donor hepatectomy must be performed with minimal or trivial risk.
Adequate vascular pedicles and bile duct must accompany the graft or be fashioned
from the recipient’s tissues. Finally, the graft must be capable of long term function
in the recipient to justify the magnitude of the procedure.
The purpose of this study was to develop, in the dog, a technique of OLT using
the left hepatic lobe.from a living donor.
ANIMALS AND METHODS
Male mongrel dogs were used. Donors weighed 25-30 kg and recipients 10-15 kg.
All studies were approved by the Animal Experimentation Committee of The
University of Chicago Division of the Biological Sciences.
Anesthesia
Anesthesia was induced by intravenous Thiamylal sodium (25mg/kg) and main-
tained, after endotracheal intubation, with 2:1 nitrous oxide-oxygen mixture with
1% halothane. Pancuronium bromide was administered and animals were artifi-
cally ventilated. Electrocardiogram and right carotid blood pressure were conti-
nuously monitored. The right external jugular vein was catheterized for infusions
and measurements of the central venous pressure. Urine output was monitored by
urethral catheterization. Lacated Ringer’s solution, dextran 70 in 5% dextrose
solution and packed red blood cells obtained from other dogs using standard
techniques were used for volume replacement. Blood compatibilities were not
assessed. Arterial blood gases were analyzed after induction and at regular
intervals and were used to adjust ventilatory support and acid-base status. The
hematocrit was checked at hourly intervals and maintained above 30% with
transfusions. Temperature was monitored with an intraesophageal thermistor
probe and controlled by a heating pad, peritoneal irrigation with warm saline and
infusion of warm IV fluids. The same technique of anesthesia was used in the donor
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Surgical Technique
Donor operation
The abdomen was entered through a bilateral subcostal incision with mid-line
extension to the xiphoid. The graft consists of the left hepatic lobe, comprising the
left lateral and left medial segments as shown in Figure 1 9. The left hepatic lobe
was inspected and the falciform, left triangular and gastrohepatic ligaments were
completely divided. The left bile duct usually has a long extra-hepatic segment and
joins the common bile duct midway between the liver and the duodenum. The left
bile duct was first ligated and divided. Its diameter was usually 1-2 mm. The left
branch of the portal vein was then exposed and dissected proximally to the portal
bifurcation. Its diameter was usually about 1 cm. Branches to the papillary process
of the caudate lobe were ligated and divided. In the dog, the common hepatic
artery has a sagittal direction and gives rise, proximal to distal, to the right hepatic
and the left hepatic branches and terminates as the gastroduodenal artery (Figure
1). The right gastric artery, which ususally originates from the left hepatic branch,
was divided. The common hepatic artery was dissected between the right and left
hepatic branches and the gastroduodenal artery was dissected as distal as possible.
This dissection was designed to isolate the left hepatic artery in continuity with the
gastroduodenal artery without altering the rest of the hepatic arterial supply. As it
enters the liver, the left portal pedicle gives rise to a branch destined to the
quadrate lobe. This branch was ligated and divided after incision of the Glisson’s
capsule. The capsule joining the papillary process of the caudate lobe and the left
lateral segment was incised and arterial and biliary branches to the caudate were
divided. The liver parenchyma was transected along an. oblique line running from
the fissure between the quadrate lobe and the left medial segment to the left side of
the supra-hepatic inferior vena cava (IVC). The left hepatic vein was identified at
the upper part of this incision at about 1.5 cm in depth and was dissected free for 1
cm in length. The lower parenchyma was crushed with a Kelly clamp and vessels
controlled by electrocautery or ligation with fine silk. This dissection leaves the left
lobe attached only by its vascular pedicles (Figure 2). At no moment during the
dissection was the graft ischemic.
Figure 3 illustrates the technique used to perfuse the liver in situ. The left portal
branch was clamped at the level of the portal bifurcation and a 14 French rubber
catheter was inserted in it and secured with an umbilical tape and tourniquet. The
common hepatic artery was ligated just proximal to the left hepatic artery as was
the" distal end of the gastroduodenal artery. The left hepatic vein was clamped as
distal as possible. Infusion 1 liter of cold Collins solution was then started through
the left portal branch by means of the rubber catheter as the left hepatic vein was
divided to vent the flush solution. The gastroduodenal artery was divided above the
tie to allow back flow of the flush solution through the left hepatic artery. Warm
ischemia of the segmental graft was thus prevented. Systemic heparinization was
used prior to perfusion because of the risk of bleeding from the cut surface of the
remaining liver. The abdomen was closed in 1 layer and the skin sutured with
interrupted stitches.
Upon removal the graft was stored in the preservation solution at 0.5C. A fibrin
sealant prepared using cryoprecipitate, thrombin and calcium
0 was spread on the










Figure Liver anatomy in the dog
Duod: duodenum, CBD: common bile duct, PV: portal vein, GDA: gastro-duodenal artery, CHA:
common hepatic artery, RHA: right hepatic artery, LHA: left hepatic artery, LBD: left bile duct, LPV:
left protal vein.
Liver segments: LL-left lateral, LC-left central, Q-quadrate, RC-right central, RL-right lateral,
C-caudate, PP-papillary process of the caudate lobe.
Recipient Operation
In addition to the vascular access described above, the left femoral and external
jugular veins were isolated for the purpose of veno-venous bypass. The same
surgical incision was used. The porta hepatis was dissected as in preparation for
routine OLT. The common bile duct and the branches of the hepatic artery were
divided as close to the liver as possible. The portal vein was dissected for a distance
of 3-4 cm up to the level of its bifurcation and the pancreatico-duodenal vein was
ligated and divided. The liver was then completely mobilized by section of its
ligaments, and the IVC was dissected free from the retroperitoneum with division
of the adrenal vein when necessary.
Spleno-cavo-jugular veno-venous bypass, after splenectomy was used (Figure 4),
powered by a centrifugal pump (Biomedicus, Medtronics, Minneapolis, Min) to
prevent mesenteric congestion . Total vascular exclusion of the liver was achieved
by portal vein occlusion and clamping of the supra-hepatic and infra-hepatic vena
cava. Veno-venous by-pass was immediately started and adjusted to achieve proper
hemodynamic response and adequate decompression of the portal vein.
Removal of the devascularized liver was begun by ligating and dividing the








Figure 2 Dissection of the left lobe graft
IVC: inferior vena cava, LHV" left hepatic vein.
possible. Then the liver was split along the medial fissure dorsally to the level of the
IVC. The common trunk of the middle and left hepatic veins was dissected and the
bridge between these 2 veins was cut in order to obtain a single larger orifice for
hepatic vein anastomosis. On the right side, 3 or 4 large hepatic veins have to be
ligated and divided. The bridge of parenchyma between the papillary and caudate
processes of the caudate lobe anterior to the IVC was divided. Small hepatic veins
draining directly into the IVC from the caudate lobe on both sides were divided.
Thus, total hepatectomy was completed while the IVC was preserved (Figure 4).
This was achieved without any bleeding due to vascular exclusion. Leaks on the
IVC were identified and sutured after releasing the infrahepatic caval clamp while
the left hepatic vein was clamped. Fibrin sealant was then spread on the exposed
IVC.
Figure 5 shows the implantation of the segmental graft. The hepatic vein of the
graft was anastomosed to the common trunk described above using continuous
suture of 5/0 polypropylene. A small opening was left on the anterior aspect of the
anastomosis to allow flushing of preservation solution from the graft. The portal
vein was connected by an end to end anastomosis using 6/0 suture. A 14 French
rubber catheter was inserted in. the portal vein before the portal anastomosis was
completed and the graft was flushed with 500 cc of warm normal saline solution.
The portal and hepatic vein anastomoses were then completed. To revascularize






Figure 3 In situ perfusion of the graft
Note that the catheter was inserted in left portal vein. Outflow of the perfusate without systemic
passage was achieved by clamping and opening the left hepatic vein. Ligation of the common hepatic
artery prior to its bifurcation and division of the gastroduodenai artery allow backflow of the perfusate in
the left hepatic arterial branch.
continuity was restored by anastomosing the distal end of the donor’s gastroduode-
nal artery to the side of the recipient’s hepatic artery at the point of bifurcation with
the gastroduodenal artery using a running suture of 7/0 polypropylene. Bile
drainage was achieved by a duct to duct anastomosis using interrupted stitches of 6/
0 polypropylene. The anterior wall of the graft’s bile duct was split vertically, when
necessary, to increase the diameter of the anastomosis. The abdomen was closed as
in the donor.
Recovery and Post-Operative Care
After recovery of spontaneous ventilation, the animals were extubated. The right
jugular catheter was tunnelled subcutaneously for purposes of administering drugs
and fluids and blood sampling. A solution of 5% dextrose in lactated Ringer’s was
infused for the first 12 hours and analgesics were injected at regular intervals.
Antibiotics (cefazolin lg/12h) were started at induction and continued postoperati-
vely in donors and recipients. Immunosuppressive therapy consisting of azathio-






Figure 4 The recipient after total hepatectomy with preservation of the IVC using veno-venous by pass
JV: external jugular vein, SV" splenic vein, FV" femoral vein
allowed the day after surgery. Liver function tests (transaminases, bilirubin,
alkaline phosphatase and prothrombin time), hematocrit, electrolytes and blood
urea nitrogen were measured daily.
Experimental Design
The study was designed in three phases:
Phase 1: To assess the feasibility of the operation, four dogs were autologously
transplanted. The left lobectomy was performed as described. Then, the remainder
of the liver was resected with preservation of the IVC after a porto-jugular bypass
had been instituted. The previously prepared left lobe was autotransplanted in the
orthotopic position.
Phase 2: To assess the feasibility of allogenic transplantation by the procedure
described, non-survival experiments were undertaken using 9 pairs of dogs. During
this phase, the technique was refined to the point that survival experiments could
be undertaken.










Figure 5 The graft after implantation in the recipient
The left hapatic vein was directly anastomosed to the inferior vena cava and the lobar vessels and bile
duct of the graft are attached to the recipienrs main vascular and biliary structures.
RESULTS
Donor Operation
Mean blood loss in the donors of the phase 3 experiments was 133 + 98 ml (range
20-300) and no animal required transfusion. The operating time was 3-4 hours.
There was no intraoperative death. The first donor died of infected liver necrosis of
the quadrate lobe on day 3. After that case, the quadrate lobe and the papillary
process of the caudate lobe were always resected. The nine other donor dogs
survived without complication. As shown on Figure 6, mild abnormalities of the
liver function tests were observed in the postoperative period, but the numbers
returned to the normal range within week in all cases. All animals were sacrificed
at day 21. Autopsy revealed a subphrenic collection in case and was unremark-
able in all other cases except for a hypertrophy of the remaining liver. Liver




0 2 4 6 8
postoperative days
Figure Ii The changes in SGPT (IU/1/10), prothrombin time (seconds) and total bilirubin (mg/dl xl0), as
seen in 9 donors after segmental liver resection (mean + SEM)
In the first 6 cases in phases 1 and 2, the graft was first removed and then flushed
ex oivo, but this resulted in poor graft appearance. After initiating in oioo
perfusion as described above, all grafts were completely blanched and soft to touch.
In situ perfusion did not result in donor reaction that might indicate passage of the
potassium rich solution into the systemic circulation. In phase 3 experiments, 9 of
10 grafts were adequate for use in allotransplantation while the other had inade-
quate vascular pedicles.
.Recipient Operation
At the beginning of phase 2, a passive portojugular by pass was used with systemic
heparinization (100 IU/kg) resulting in uncontrollable hemorrhage after total
hepatectomy. The use of the centrifuge pump without heparin and total vascular
exclusion of the liver made the total hepatectomy much easier, quicker and
bloodless. The hemodynamic tolerance to bypass was excellent. The mean time of
venous bypass was 90 _
16.2 min (range 75-120). No thrombotic complications
were encountered.
There were 2 intraoperative deaths in phase 2 due to hemorrhage and 2 in phase
3 resulting from cardiac arrest at reperfusion and air embolus. An outflow block of
the graft occurred after reperfusion in 7 instances (3 in phase 2 and 4 in phase 3)
causing liver congestion and portal hypertension, this phenomenon has been
frequently observed in canine liver transplantation ’-, but in the setting of
segmental liver transplantation it was a particular problem because it led to diffuse198 D. CHERQUI ET AL.
bleeding from the graft’s transected surface in all cases. The block was reversible in
all animals, which indicated the method of hepatic vein anastomosis not to be at
fault, but coagulopathy and persistent bleeding were secondarily observed. In the
absence of outflow block, revascularization and perfusion of the graft were
excellent, and no bleeding from the graft’s cut surface was observed.
Mean blood loss and transfusion requirements in phase 3 experiments were 493
+ 432ml (range 150-1300) and 2.14 + 1.34 units of packed red cells (range 0-4)
respectively. The operating time was 3-4.5 hours.
In phase 3 experiments, 2 dogs died intraoperatively. Three dogs survived the
immediate postoperative period, two for 24 hours and one for 48 hours. They were
awake and alert several hours after surgery, but eventually died of pulmonary
edema in 2 cases and of an unknown reason in the other. SGOT were 1500, 1300
and 800 IU/I and prothrombin time was 13, 14.5 and 11.5 seconds respectively one
day after transplant. At autopsy there was no hemoperitoneum or ascites, no liver
necrosis, bile was present in the bile duct and all anastomoses were patent. Four
dogs died 2-12 hours postoperatively as a result of hemorrhage from the graft’s
transected surface. Persistent outflow block was deemed to be the cause of
hemorrhage in these cases, as mentioned above. At autopsy, there was hemoperi-
toneum without clots, all anastomoses were patent, there was no liver necrosis and
there was evidence of bile production in 2. On histologic examination of the grafts,
there were no signs of ischernic necrosis or preservation damage (Figure 7).
Figure 7 Histology of post-mortem liver biopsy in a 48-hour recipient survivor
There was no evidence of ischemic necrosis. Central and pericentral regional hepatocytes are well
preserved. Portal areas contain a minimal infiltrate consisting primarily of large lymphocytes. There are
no vascular lesions. (H & E, x 400)LIVING HEPATIC ALLOGRAFT DONATION 199
DISCUSSION
This study is, to our knowledge, the first report of an attempt at liver transplan-
tation from a living donor. The results show that it was possible, in the dog to:
harvest non-ischemic segmental liver grafts with adequate vascular pedicles and
bile duct from a living donor without altering the vascularization and the biliary
drainage of the remaining liver;
2 perform a total hepatectomy in the recipient with
preservation of the IVC; and achieve adequate revascularization of a segmental
liver graft using segmental vessels and bile duct and orthotopic hepatic venous
anastomosis.
The cornerstones of the technique reported herein are twofold: meticulous
dissection of the hilus structures in the donor, identifying all the pedicles and
avoiding warm ischemia of the graft, and use of total vascular exclusion of the
liver associated with spleno-cavo-jugular venous bypass in the recipient. Although
many experimental studies of segmental liver transplantation have used heterotopic
and/or auxiliary positioning of the graft 4-19, we chose to use an orthotopic
non-auxiliary technique. Because of previous observations that optimal venous
drainage of a liver graft was achieved when it was placed as close as possible to the
diaphragm
18,20 and that heterotopic grafts can be lost due to inadequate outflow
conditions 21, we chose orthotopic positioning. We also avoided auxiliary transplan-
tation by excision of the whole native liver. In other techniques of segmental OLT,
the liver parenchyma was reduced in size by an extracorporeal hepatectomy, but
the pedicles of the whole liver are used for anastomosis (i.e. IVC, portal vein trunk,
celiac trunk and common bile duct) 22,23. In the present study, segmental portal
pedicles and the left hepatic vein were used for reconstruction. The size ratio that
we chose between donor and recipient dogs made this possible, as might be the case
of a parent providing a hepatic allograft for a child.
The application of this technique to human transplantation depends upon a
sufficiently low risk to the donor. In these experiments, donor survival was
excellent. The hepatectomy performed for the purpose of supplying a graft is not
the same as for the resection of an isolated pathologic process. The vascular
pedicles must be retained for both the graft and the remaining liver. It also must
include in situ perfusion and cooling of the lobe to be resected. This study provides
a safe technique to achieve these purposes.
The technique of harvest described herein is applicable to human liver segmental
anatomy
24, 25 (Figure 8). We have confirmed this possibility by dissections of human
cadaver livers. Although left lateral segmentectomy (segments 2 and 3) is certainly
the safest formal liver resection, the donor operation should be a left hepatectomy
(segments 2, 3 and 4) in order to obtain adequate extrahepatic pedicles and, more
importantly, to avoid leaving a compromised quadrate lobe in the donor.
Abnormal arterial supply to the liver does not preclude the procedure and can be
assessed by a preoperative angiogram. The left hepatic duct has an extra-hepatic
segment which can be sewn to a Roux-en-Y intestinal loop. Biliary drainage of part
of the right liver in the left hepatic duct exists in 6% of the cases according to
Couinaud z4. Such an anomaly should be sought by a preoperative cholangiogram
and considered as a contraindication.
Recent advances in liver surgery have dramatically reduced the operative risk of
elective hepatic resections. These advances have permitted hepatic resections with
minimal or no blood transfusions. They include mastering of surgical technique,200 D. CHERQUI ETAL.
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Figure 8 Segmental liver anatomy in humans according to Couinaud
better knowledge of anatomy and new technology such as intraoperative ultra-
sound and ultrasonic dissectors 26. Mortality of elective hepatic resections for
benign liver lesions, including large hypervascular tumors, has been reported to be
as low as 1-2% 26,27. Elective hepatic resection in a totally healthy patient
performed by an expert surgeon can be expected to be performed with an
extremely low risk. Morbidity including fluid collections and bile leaks can be
avoided by meticulous hemostasis and ligation of small bile ducts. Non specific risks
such as thrombo-embolic and septic complications have been accepted in living-
related kidney and pancreas transplantation and should not be greater in living liver
donors. Liver function has been proven to remain normal after resections of more
than 50% of the liver if the parenchyma was normal 2s. The projected resection in
living donation does not exceed 35-40% of the liver mass29. Moreover, the capacity
of the liver for regeneration will permit a full recovery of the hepatic functioning
28 mass
Also required for application to human transplantation is a graft which functions
and supports life in the recipient. In these experiments, the recipient survival was
poor. This can be ascribed to the extensive recipient operation, which was
analogous to human reduced-size liver transplantation and was performed in small
dogs. The main cause of death was hemorrhage from the graft’s cut surface, which
only occurred in those cases where an outflow block of the graft was observed after
reperfusion. This problem is specific to the canine model 11.2 and has not been
reported in humans or other species. Dogs, which are exquisitely sensitive to portal
vein clamping, require complex bypass techniques during the anhepatic phase. In
contrast, cirrhotic infants undergoing OLT tolerate prolonged portal and caval
clamping without appreciable hemodynamic consequences. Moreover, postopera-
tive care, while intensive by animal experimentation standards, did not approxi-
mate that delivered in clinical intensive care units and was insufficient for survivalLIVING HEPATIC ALLOGRAFT DONATION 201
in these animals. However, there was evidence of bile production by the graft in 5
cases, histologic examination of the grafts showed normal parenchyma, and three
dogs survived for 24-48 hours and were alert with normal liver function.
Our previous work 3,4, as well as that of others 2,5, have shown that left lobe
segmental grafts can result in long term survival with normal liver function in infant
hepatic allograft recipients._Bismuth and Houssin have reported a case of auxiliary
orthotopic segmental OLT showing that direct anastomosis of the left hepatic vein
was possible in humans 30. Total hepatectomy with preservation of the IVC was
perfectly feasible in humans 31,32. Recently, it has been shown that human cadaver
livers can be split into 2 grafts. This has been performed successfully in Germany
6
and in France (H. Bismuth personal communication). We have performed this
technique in 7 pairs of patients. Six of 7 infants receiving left lobe grafts without the
vena cava are alive with a technique analogous-to that of the recipient dogs
described in the present study (manuscript in preparation).
There are severa.1 potential advantages to the use of living-related hepatic
allograft donors in pediatric transplantation. Many children, particularly infants,
die without the benefit of transplantation. This mortality can be reduced by using
reduced-size allografts, splitting organs for use in 2 recipients, and by living donors.
Living related donation may also offer immunologic advantage. Parent to child
donation results in at least 1 haplotype HLA identity (except for exceptional
translocations). Low stimulation mixed lymphocyte culture (MLC) in nonidentical
living related kidney transplantation has been shown to significantly increase the
graft survival 33. Thus, haplotype identity and low stimulation MLC are very likely
to increase liver graft survival and should be a prerequisite to consider the
procedure. Also, living related donors can undergo extensive preoperative evalu-
ation which would assure normal liver function and avoid graft dysfunction owing
to undetected hypotension, drug usage, or other factors often encountered in
cadaveric donors. Finally, the procedure could be performed under optimal
elective operative conditions.
In conclusion, this study, combined with the clinical experience using reduced
liver grafts in children, shows the technical feasibility of living hepatic allograft
donation.
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INVITED COMMENTARY
The work reported by the liver transplant group at the University of Chicago
represents a major conceptual advance in the field of liver transplantation, and is a
logical extension of the important work recently reported by this group in providingLIVING HEPATIC ALLOGRAFT DONATION 203
transplants to two recipients from a single donor. This paper, which addresses the
problems of finding livers for paediatric recipients, succeeds in demonstrating the
feasibility of living-related organ donation in the area of liver transplantation, a
concept which has lorrg been in practice with kidney tranplants, and more recently
has been extended to the area of pancreatic grafts.
The authors correctly point out that the limiting factor in the applicability of this
technique rests with the ability of the liver team to carry out major hepatic
resections with minimal morbidity and virtually no mortality. Improvements in
surgical technique have made this eminently possible, and the resection of a left
lobe in a healthy adult should carry less hazard than a segmental pancreatic
resection which has proven to be acceptable.
A number of questions remain to be answered. The high mortality in the phase 3
recipients is certainly higher than would be expected for dogs receiving whole organ
tranplants. In the phase 3 recipients, the mortality rate was 100%. Two dogs died
from technical complications of re-perfusion with air emboli, four dogs died in the
first 12 hours after transplantation from hemorrhage, and three died between the
first and second post-operative days from other causes. While the three late post-
operative deaths and the two intra-operative deaths may not be related to problems
with the liver itself, the four deaths from hemorrhage are cause for concern. These
dogs are described to having had a severe hemorrhagic condition from the cut
surface of the liver aggravated by hepatic outflow obstruction. It is possible that the
practice of anastomosis of the left hepatic vein to the vena cava may not provide the
same free drainage of venous blood as is usually obtained in the whole organ
transplant, and that this technique may be prone to the mechanical complications
such as kinking of the venous outflow tract. This problem has not been reported in
human transplantation using the left hepatic vein as the outflow tract, and may be a
problem as the authors state, peculiar to dogs.
The experience in this paper has been limited to donors and recipients whose
weight ratios do not exceed 3:1. In the human situation, the parent to child weight
ratio may greatly exceed this figure, and make the procedure more difficult because
of limitations in available space. The early proponents of the use of reduced-size
liver transplants have expressed relectance to exceed weight ratios of greater than
8:1.
The anatomy of the dog liver with its long segment of extra-hepatic left biliary
duct and left hepatic artery lends itself more readily to this procedure than the
human liver where the technical challenge of anastomosing the small artery and
duct in the left lobe may be made more difficult than in the dog because of the short
extra-hepatic lengths of these structures.
Before this technique can be safely applied to humans, it may be wise to attempt
this procedure in primates or baboons in which the anatomy of the liver and the
weight differences between recipients and donors would be more comparable to
that likely to be encountered in human transplants.
In addition to solving some of the problems of donor availability for small infants
and patients with fulminant hepatic failure, this technique provides for optimal
timing in transplantation before recipient deterioration occurs which may jeopar-
dize a successful outcome. The use of living related donor liver transplantation will
also allow transplanters to discover if the use of donor antigen pre-treatment by
pre-transplant transfusions of donor blood may decrease the severity of rejection
and improve long-term results as has occurred in the area of living related renal
transplantation and experimental models of liver transplantation in animals.204 D. CHERQUI ETAL.
When this technique is eventually used for human transplantation, the most
difficult decision may be the timing of the procedure" when will the risks to the
patients of further delays caused by the search for a cadaver donor outweigh the
risks to the parent inherent in any major surgical procedure.
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